October 13, 2016
1 min read

Nine important updates for World Thrombosis Day

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Today is World Thrombosis Day, an observance designed to increase awareness about blood clots.

In conjunction with this observance, HemOnc Today presents nine important updates in thrombosis prevention and treatment.

  • Statin use decreased risk for recurrent venous thrombosis in patients who had experienced an incident venous thrombosis. Read more.
  • A family history of thrombosis may increase risk for venous thromboembolism among women who take oral contraceptives. Read more.
  • Genetic factors that predicted venous thrombosis in younger patients remained predictive in older cohorts. Read more.
  • The development of postthrombotic syndrome in children with lower-extremity deep vein thrombosis appeared related to DVT triggering event, sex and residual thrombosis. Read more.
  • Therapeutic anticoagulation therapy decreased already-low rates of proximal deep vein thrombosis and pulmonary embolism among patients with isolated calf DVT. Read more.
  • Early initiation of venous thromboembolism prophylaxis appeared associated with decreased risk for pulmonary embolism and deep vein thrombosis in patients with severe traumatic brain injury. Read more.
  • Approximately 10% of newly diagnosed patients with acute myeloid leukemia will develop venous and arterial thrombosis after treatment with intensive chemotherapy. Read more.
  • HemOnc Today spoke with Nigel S. Key, MD, about research priorities in the field of cancer-related venous thromboembolism. Read more.
  • Routine thrombophilia testing should not be recommended for children with central venous catheter–associated deep vein thrombosis. Read more.